28 April 2022
: Case report 
Use of Lithium in Hyperthyroidism Secondary to Graves’ Disease: A Case Report
Unusual clinical course, Challenging differential diagnosis, Diagnostic / therapeutic accidents, Unusual setting of medical care, Unexpected drug reaction
Pranjali P. Sharma1ABDEF*DOI: 10.12659/AJCR.935789
Am J Case Rep 2022; 23:e935789
Tabel 1. Antibody levels at Day 1 and Day 60 of Li carbonate therapy.
| Antibodies | Day 1 | Day 60 |
|---|---|---|
| TSH receptor Ab (≤1.75 IU/l) | >40 | >40 |
| Thyroid stimulating immunoglobulin (≤122%) | 178 | 114 |